| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $18.2M | -1.0% | +7.5% |
| SG&A Expense | $4.3M | -3.7% | -12.7% |
| Operating Income | -$22.5M | +1.6% | -2.9% |
| Pre-tax Income | -$21.1M | +0.7% | -10.0% |
| Income Tax | -$6K | -220.0% | -108.1% |
| Net Income | -$21.1M | +0.7% | -9.5% |
| EPS (Basic) | -$0.40 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.3M | -17.7% | -25.6% |
| Short-term Investments | $92.9M | -5.3% | -30.7% |
| Current Assets | $132.4M | -8.9% | -30.2% |
| Total Assets | $133.8M | -12.4% | -40.1% |
| Current Liabilities | $12.3M | +6.0% | -9.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$56.4M | — | — |
| Capital Expenditures | $14K | — | — |
| Investing Cash Flow | $51.7M | — | — |
| Financing Cash Flow | $113K | — | — |
| Free Cash Flow | -$56.4M | — | — |
| +2.4% |
| -8.1% |
| EPS (Diluted) | -$0.40 | +2.4% | -8.1% |
| $12.8M |
| +4.9% |
| -49.8% |
| Stockholders' Equity | $121.0M | -13.9% | -38.9% |